Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors

Shu Feng(Baylor College of Medicine), Michael Ittmann(Baylor College of Medicine)
Oncotarget
December 20, 2016
Cited by 23


Related Papers